-
Innovation Ranking
NewInnovation Ranking – AT&T Inc
AT&T Inc (AT&T) is a provider of telecommunications, media, and technology services. The company offers wireless communications, data/broadband and internet services, local and long-distance telephone services, telecommunications equipment, managed networking, and wholesale services. AT&T also develops, produces, and distributes feature films, television, gaming, and content in physical and digital formats. It also provides advertisement and entertainment services. The company serves individual customers and business enterprises. It markets services under AT&T, Cricket, SKY, AT&T TV, AT&T PREPAID, AT&T Fiber, and Unefon...
-
Innovation Ranking
NewInnovation Ranking – T-Mobile US Inc
T-Mobile US Inc (T-Mobile), a subsidiary of Deutsche Telekom AG, is a provider of telecommunication services. The company offers wireless telecommunications services and a host of other services, including voice, text messaging, video calling, and data communications to the customers. T-Mobile serves postpaid, prepaid, and wholesale customers. The company provides wireless internet access and other data services to commercial centers. It also carries out the distribution of a wide range of mobile phones, wearables, tablets, and mobile phone accessories from...
-
Innovation Ranking
NewInnovation Ranking – M&T Bank Corp
M&T Bank Corp (M&T) is a bank holding company that offers banking, mortgages, investments and insurance, and business solutions through its subsidiaries. Banking products comprise accounts, cards, loans, deposit services, and investment banking. Mortgage solutions consist of refinancing, financing solutions, and loan sweep services. Investments and insurance solutions include life and non-life insurance, and retirement planning services. Business solutions comprise business succession, custody, and employee benefits services. The company operates through a network of branch offices, ATMs, and online portals...
-
Innovation Ranking
NewInnovation Ranking – Samsung C&T Corp
Samsung C&T Corp (Samsung C&T) is a diversified company. It operates various businesses including engineering and construction, trading and investment, fashion, and resort businesses. The company also carries out the building, civil infrastructure, urban development, plant, and housing construction works. Samsung C&T carries out trading of chemicals, iron and steel, industrial materials, energy and mineral resources, and supplies plants for the textile industry. The company also offers a wide range of clothing and accessories for men and women under brands...
-
Product Insights
Likelihood of Approval Analysis for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that the drugs in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. T-Cell Acute Lymphocytic Leukemia (T-Cell Acute...
-
Innovation Ranking
NewInnovation Ranking – L&T Technology Services Ltd
L&T Technology Services Ltd (L&T Technology), a subsidiary of Larsen & Toubro Ltd, is a provider of digital engineering, development and consultancy services. The company provides product, manufacturing and operating engineering services in the fields of mechanical, manufacturing automation, security, software development, smart factory, wearable IOT and embedded systems. Its service offerings include software and hardware product design and development, maintenance, testing and validations; agile supply chain; integrated content management; security monitoring; industrial AI and plant engineering; among others. L&T...
-
Product Insights
Likelihood of Approval Analysis for Cutaneous T-Cell Lymphoma
Overview How likely is it that the drugs in Cutaneous T-Cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cutaneous T-Cell Lymphoma Overview Cutaneous T-cell lymphoma (CTCL) is a rare...
-
Product Insights
Likelihood of Approval Analysis for Peripheral T-Cell Lymphomas (PTCL)
Overview How likely is it that the drugs in Peripheral T-Cell Lymphomas (PTCL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral T-Cell Lymphomas (PTCL) Overview Peripheral T-cell lymphomas (PTCL) constitute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linperlisib in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linperlisib in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linperlisib in T-Cell Acute Lymphocytic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-103 in T-Cell Acute Lymphocytic...